The NAD+/NADH Ratio: Redefining Mitochondrial Efficiency Beyond ATP

The concentration of total NAD+ is less significant than the ratio between its oxidized (NAD+) and reduced (NADH) forms. This ratio, ideally 700:1 in the cytoplasm and significantly lower in the mitochondria, dictates the thermodynamic 'pull' for energy production. When we consume excess calories—particularly refined carbohydrates—without adequate physical output, we flood the system with electrons, converting NAD+ into NADH faster than the electron transport chain can utilize it. This results in a low NAD+/NADH ratio, a state known as reductive stress. Conventional UK medicine lacks a standardized test for this ratio, yet it is the primary driver of insulin resistance and mitochondrial dysfunction.

Sirtuins, the longevity-linked proteins, are NAD+-dependent deacetylases. They cannot function when NADH levels are too high, as NADH acts as a competitive inhibitor. Consequently, even if a patient has 'normal' B3 levels, their sirtuins may be dormant due to an unfavorable redox state. This suppresses SIRT1's ability to activate PGC-1alpha for mitochondrial biogenesis and SIRT3's ability to quench mitochondrial ROS. The result is a downward spiral of declining energy and increased DNA damage.

Research into 'Redox medicine' suggests that interventions like cold exposure, fasting, and intense exercise are effective because they force the oxidation of NADH back into NAD+, restoring the ratio. Furthermore, the use of exogenous ketones or small molecules like Methylene Blue can act as electron cyclers to bypass blocks in the electron transport chain. For the sophisticated health consumer, the goal is not just 'more NAD+' but a higher oxidative capacity. This requires a shift from chronic over-nutrition to a lifestyle that promotes 'metabolic flexibility,' allowing the cell to maintain a high NAD+ pressure that keeps the sirtuins active and the mitochondria resilient against the oxidative stressors of modern life.